INTRODUCTION
Posttranslational attachment of Ubiquitin (Ub) marks proteins for various cellular fates and functions, including proteasomal degradation, endocytosis, endosomal sorting, and DNA repair. In general, three enzymes catalyze the ubiquitination reaction: a Ub-activating enzyme (E1), a Ubconjugating enzyme (E2), and a specificity-determining Ub-protein ligase (E3; Herschko and Ciechanover, 1998) . Ub ligases fall into two categories; HECT domain E3s form a Ub thioester intermediate via a strictly conserved cysteine residue, while RING finger and U-box E3s act as scaffolding proteins that indirectly enhance Ub transfer from the E2 conjugate to the substrate. One class of HECT domain E3s is characterized by a common modular organization with an N-terminal C2 domain that can mediate membrane localization, two to four WW domains that recognize proline-rich motifs of substrates or adaptor proteins, and a C-terminal HECT domain that catalyzes isopeptide bond formation between the Ub C terminus and the substrate lysine residue (Ingham et al., 2004) .
Although ubiquitination has important implications for cellular function, the mechanisms that regulate the ubiquitination reaction are largely unknown. Smurf1 (Smad ubiquitination-related factor 1) and Smurf2 are closely related C2-WW-HECT-domain E3s that play important roles in the downregulation of the TGF-b signaling pathway Zhu et al., 1999) . TGF-b proteins are key morphogens that control a variety of developmental processes, including cell growth, differentiation, and self-renewal. Interaction of TGF-b morphogens with TGF-b receptor complexes initiates intracellular signaling cascades involving Smad proteins (Feng and Derynck, 2005) and the polarity protein Par6 (Ozdamar et al., 2005) . Upon TGF-b-induced expression, the inhibitory adaptor protein Smad7 forms a complex with the Smurf2 Ub ligase in the nucleus . Association of Smurf2 with Smad7 serves at least three regulatory functions; it stimulates Smurf activity by recruiting the E2 to the HECT domain , induces the export of the Smurf2-Smad7 complex to the cytoplasm, and mediates its interaction with TGF-b receptors resulting in the ubiquitination of TGF-b receptors, Smad7, and Smurf2 itself to ultimately terminate TGF-b signaling .
Smurf proteins also regulate cell shape, motility, and polarity by degrading small guanosine triphosphatases (GTPases). While Smurf2-dependent degradation of the GTPase Rap1B is required for the establishment of neuronal polarity, Smurf1 targets RhoA in migrating and polarized epithelial cells (Ozdamar et al., 2005; Schwamborn et al., 2007; Wang et al., 2003) . Smurf1 activity toward RhoA is spatially restricted to membrane protrusions in migrating cells or tight junction regions in epithelial cells by the polarity proteins atypical protein kinase C and Par6 (Ozdamar et al., 2005; Wang et al., 2003) . Growing evidence suggests that dysregulation of Smurf-dependent degradation of components of TGF-b signaling pathways leads to developmental defects and plays important roles in cancer pathogenesis and metastasis (Izzi and Attisano, 2004) .
Ubiquitination is one of the most abundant posttranslational protein modifications. Yet, it is poorly understood how the ubiquitination machinery itself is regulated to prevent autocatalytic degradation of the core components. Although Ub protein ligases have largely been considered to be constitutively active and regulated only at the level of target binding, it has become evident recently that HECTtype E3s are subject to regulation either by E3 or substrate phosphorylation or by utilization of adaptor proteins that facilitate E2 recruitment (Kee and Huibregtse, 2007) . Here, we report the solution structure of the N-terminal Smurf2 C2 domain and show that it interacts with the C-terminal HECT domain in the vicinity of the catalytic cysteine. This interaction inhibits Smurf2 Ub ligase activity in vitro and in vivo by interfering with Ub thioester formation and serves to stabilize Smurf2 and substrate steady-state levels in cells. We propose a model for the regulation of the HECT-type Ub ligase Smurf2 through intra-and intermolecular interactions.
RESULTS
The C2 Domain, but Not the WW1 Domain, Interacts with the HECT Domain of Smurf2 To investigate whether the catalytic activity of the C2-WW-HECT-E3 Smurf2 is regulated by intramolecular domain-domain interactions, we explored potential interactions between the Smurf2 C2 or WW1 domain and the HECT domain using NMR chemical shift perturbation studies. In combination with resonance assignments and 3D protein structures, NMR titrations provide direct information about which residues are located in binding sites. The crystal structure of a Smurf2 WW2-WW3-HECT domain construct revealed no electron density for the two WW domains , indicating that they are not likely engaged in a stable intramolecular interaction with the HECT domain. Therefore we focused our efforts on the N-terminal C2 domain and the first WW domain.
Addition of Smurf2 WW1 domain to 15 N-labeled HECT domain resulted in no significant chemical shift changes in the 1 H, 15 N-correlation (HSQC) spectrum of the HECT domain even at a large excess of WW1 domain ( Figure 1A ). Figure 1C ).
Furthermore, stepwise addition of the ligand increased line-broadening in both spectra due to the higher molecular weight of the complex formed ($62 kD). Together, these data demonstrate that the N-terminal C2 domain of Smurf2 binds the C-terminal HECT domain, even when added as an isolated polypeptide.
Solution Structure of the Smurf2 C2 Domain
In order to map the residues affected by HECT domain binding onto the structure of the C2 domain, we assigned >98% of all 1 H, 13 C, and 15 N resonances of the Smurf2 C2 domain and determined its solution structure by heteronuclear NMR spectroscopy. As shown in Figure 2A , the ensemble of the 20 lowest-energy NMR structures is well defined except for loop regions. Structural statistics are summarized in Table S1 . The Smurf2 C2 domain adopts the typical C2 domain b sandwich fold composed of two four-stranded, antiparallel b sheets ( Figure 2B ). The fold also contains two a helices that connect b strands 5 and 6 (aa 82-87; aI) and b strands 6 and 7 (aa 107-116; aII). Overall, the structure of the Smurf2 C2 domain is very similar to those of other C2 domains with a backbone RMSD of 2.8 Å when compared to the PKCa C2 domain in complex with two Ca 2+ -ions and phosphatidyl serine (PDB ID: 1DSY; Figures 2B and 2C) .
Although C2 domains share a common fold, they exhibit at least two different secondary structure topologies that are achieved by a circular permutation of the b strands placing the N-and C terminus at either the top (class I) or bottom (class II) of the b sandwich and may have a short a helix either between strands b7 and b8 (class IB) or between strands b6 and b7 (class IIB; Ubach et al., 1999) . Together with the relatively low overall sequence similarity, these alternative secondary structure topologies represent potential pitfalls for the homology modeling of C2 domain structures. Based on our solution structure, the Smurf2 C2 domain can clearly be identified as a class IIB C2 domain ( Figure 2B ). Furthermore, sequence similarity among C2 domains of Nedd4/Rsp5p-family proteins indicates that the class II C2 domain fold is evolutionarily conserved across the entire family of C2-WW-HECTdomain Ub ligases ( Figure S1 ).
The Smurf2 C2 Domain Interacts with Phosphoinositides via an Interface that Overlaps with the HECT Domain Binding Site With a full resonance assignment and the solution structure of the Smurf2 C2 domain in hand, we mapped the residues affected by HECT domain binding ( Figure 1C ). This revealed that the HECT domain interacts with a hydrophobic and positively charged surface patch on the C2 domain that is composed of residues in the b1-b2 and b3-b4 loops, the aI helix, and the aI-b6 loop ( Figures 3A and S2A ). C2 domains were first identified as phospholipid-binding modules (Rizo and Sudhof, 1998) . To characterize Smurf2 C2 domain-phospholipid interactions in more detail, we performed protein lipid overlay assays. Of all 15 lipids tested, the Smurf2 C2 domain interacted with phosphatidyl mono-, bi-, and triphosphates (PtdIns(3)P, PtdIns(4)P, PtdIns(5)P, PtdIns(3,4)P 2, PtdIns(3,5)P 2 , PtdIns(4,5)P 2 and PtdIns(3,4,5)P 3 ) and with phosphatidic acid (PA) in a Ca 2+ -independent manner ( Figure S2B ). Except for the PA interaction, these results are in close agreement with the phospholipid-binding specificities of Rsp5p (Dunn et al., 2004) . Using NMR titrations with unlabeled Ins(1,3,5)P 3 and 15 N-labeled Smurf2
C2 domain ( Figure S2C ), we mapped the phospholipidbinding surface to hydrophobic and positively charged C2 domain residues in the b1-b2 loop, the b5-b6 loop including helix aI, and the b7-b8 loop ( Figure 3B ). This Ins(1,3,5)P 3 binding site is consistent with the close structural similarity to the PKCa C2 domain complex (Figure 2C Tugarinov et al., 2003) . Using Smurf2 HECT domain exclusively labeled at isoleucine-d1 positions, we obtained high-quality 1 H, 13 C-correlation (HMQC) methyl spectra that could be used for chemical shift mapping studies ( Figure 3C ). This approach is thus a useful alternative to 1 H, 15 N-based chemical shift perturbation studies for proteins with limited stability and/or solubility. As in the 1 H, 15 N-based chemical shift titration ( Figure 1B ), a subset of resonances of the Smurf2 HECT domain changed in the methyl HMQC spectra upon stepwise addition of the C2 domain ( Figure 3C ).
To map the isoleucine residues affected by C2 domain binding onto the structure of the HECT domain, we generated six isoleucine mutants of the Smurf2 HECT domain and compared their 1 H, 13 C methyl spectra with that of the wild-type HECT domain. In a previous experiment, the catalytic cysteine-containing HECT domain C-lobe was not sufficient for an interaction ( Figure S3 ). Therefore, we mutated isoleucine residues in the N-lobe close to the active site cysteine or located at the interface between the Nand C-lobes ( Figure S4A ). Comparison of the mutant and wild-type spectra resulted in the unambiguous assignment of four of the six isoleucine mutants ( Figure S4B ).
Intriguingly, the isoleucine residues affected by C2 domain binding (I402 and I489) map to a hydrophobic/acidic surface patch in direct vicinity of the catalytic cysteine (C716) of the HECT domain ( Figures 3D and S5 ). This suggests a regulatory function for the interaction between the C2 and HECT domains.
The Interaction of the Smurf2 C2 and HECT Domains Inhibits Ub Thioester Formation To test whether the interaction between the Smurf2 C2 and HECT domains indeed regulates HECT domain activity, we performed Ub thioester assays with wild-type Smurf2, a Smurf2 mutant lacking the C2 domain (Smurf2 DC2) and catalytically inactive Smurf2. In the latter, the active-site cysteine was mutated to alanine (CA mutant). Protein levels of unmodified and ubiquitinated Smurf2 were analyzed by SDS-PAGE in the presence or absence of DTT as reducing agent and immunoblotting with aSmurf2 antibody. In preliminary experiments, the DC2 mutant ubiquitinated itself so efficiently that isopeptidelinked monoubiquitinated DC2 obscured the formation of DTT-sensitive Ub thioester adducts (data not shown). Therefore, we used Smurf2 variants truncated by four residues from their C-termini (''À4aa'') in subsequent Ub thioester assays, as this abolishes Ub isopeptide-linkage without affecting thioester formation (Salvat et al., 2004) .
No ubiquitination of wild-type -4aa Smurf2 was observed in the Ub thioester assays ( Figure 3E ). In contrast, the DC2 -4aa mutant readily formed thioester-, but not isopeptide-linked Ub adducts, as revealed by the presence of a reduction-sensitive DC2$Ub adduct. Together with the chemical shift mapping studies ( Figures 3C-3D ), these results suggest that the C2 domain inhibits Smurf2 activity by obstructing accessibility of the catalytic cysteine of the HECT domain, thus blocking Smurf2$Ub thioester formation.
Deletion of the C2 Domain Enhances Smurf2 Autoubiquitination In Vitro
Having established an inhibitory role of the C2 domain for Smurf2 function, we next addressed the effect of the C2 domain on Smurf2 autoubiquitination. To this end we performed in vitro ubiquitination assays using wild-type Smurf2, the DC2 mutant, and the isolated Smurf2 HECT domain. Protein levels of unmodified and ubiquitinated Smurf2 at different time points in the reaction were analyzed by SDS-PAGE and immunoblotting with a-Smurf2 and a-Ub antibodies. As shown in Figures 4A and S6 , the level of unmodified wild-type Smurf2 did not change significantly during the course of the reaction (top panel), with little ubiquitinated Smurf2 detected after 2 hr (bottom panel). In contrast, most of the core DC2 protein was modified to ubiquitinated species by the end of the reaction in a manner similar to the isolated HECT domain (Figures 4A and S6) . Thus, deletion of the C2 domain enhances autoubiquitination of Smurf2. Of note, our previous work revealed a role for Smad7 in stimulating Smurf2 ubiquitination by facilitating E2 binding to the HECT domain -ions and phosphatidyl serine (PDB ID: 1DSY; shown in green). The class I secondary structure topology of the PKCa C2 domain is indicated in green on the bottom. . Consistent with these findings, addition of Smad7 to the DC2 mutant further enhances Smurf2 ubiquitination (data not shown).
Interfering with the C2 and HECT Domain Interface Enhances Smurf2 Autoubiquitination In Vitro Based on the results of the NMR analysis, we introduced site-directed C2 domain mutations into full-length Smurf2 that were designed to interfere with the interaction between the C2 and HECT domains. C2 domain residues that displayed the most significant chemical shift perturbations upon HECT domain binding ( Figure 3A ) were mutated to alanine in the case of hydrophobic residues and to glutamate for basic residues. In total, we generated six mutants and tested their autoubiquitination efficiency by comparing protein levels of unmodified and ubiquitinated Smurf2 ( Figure 4B ). Smurf2 variants in which the C2 domain hydrophobic residues involved in HECT domain binding were mutated (F29A/F30A and T56A/L57A) displayed the highest ubiquitination levels. These residues also displayed the largest chemical shift changes upon HECT In vitro autoubiquitination assays using bacterially expressed and purified wild-type Smurf2, Smurf2 DC2 mutant, or Smurf2 HECT domain were analyzed by immunoblotting with a-Smurf2 (top panel) and a-Ub antibody (bottom panel). (B) Mutations in the C2 domain designed to interfere with HECT domain binding enhance Smurf2 autoubiquitination. In vitro autoubiquitination assays using bacterially expressed and purified wild-type Smurf2, DC2 mutant, and C2 domain mutants in the context of full-length Smurf2 were analyzed after a reaction time of 1 hr by immunoblotting with a-Ub antibody (top panel, ''In vitro reaction''). Equivalent Smurf2 levels in the starting material (''Totals'') were confirmed by immunoblotting with a-Smurf2 antibody (bottom panel). (C) C2 domain deletion and impaired interactions between the C2 and HECT domains destabilize Smurf2 in vivo in a manner that is dependent on the active site cysteine. HEK293T cells were transiently transfected with empty vector, Flag-tagged wild-type Smurf2, the DC2 mutant or C2 domain domain binding ( Figure S2A ). In contrast, mutations of individual basic residues in the interface had modest or no effect. Thus, interfering with the interface between the C2 and HECT domains enhances Smurf2 autoubiquitination.
To further examine whether full-length and DC2 Smurf2 contain the same number of ubiquitination sites, we carried out autoubiquitination assays using wild-type, DC2, F29/30A, or catalytically inactive (CA) Smurf2 in combination with either wild-type or lysine-less (K0) Ub ( Figure S7) . In contrast to wild-type Ub, K0 Ub cannot form polyUb chains. Both the DC2 and F29/30A Smurf2 mutants formed discriminate monoubiquitinated species conjugated with up to three K0 Ub moieties. This suggests that both full-length and DC2 Smurf2 contain three major ubiquitination sites. In contrast, we detected no ubiquitination of wild-type Smurf2 using wild-type and K0 Ub. This is likely due to the C2 domain inhibiting Ub thioester formation and the less efficient use of K0 Ub in HECTdomain-mediated ubiquitination (Woelk et al., 2006) . Of note, preliminary mass spectrometric analyses of the monoubiquitinated Smurf2 species indicate that none of the three major ubiquitination sites maps to the interaction surface of the C2 and HECT domains (unpublished data).
The Smurf2 C2 and HECT Domains Interact in an Intramolecular Manner
To examine whether the interaction between the Smurf2 C2 and HECT domains occurs in an intra-or intermolecular manner, we next tested whether addition of the isolated Smurf2 C2 domain inhibits autoubiquitination of the DC2 mutant in trans ( Figure S8A) . While the low level of autoubiquitination of wild-type Smurf2 was virtually unaffected by the presence of increasing amounts of isolated C2 domain, the levels of autoubiquitinated DC2 mutant decreased with increasing concentrations of isolated C2 domain. Based on this result, we next explored whether the catalytically inactive (CA) Smurf2 inhibits autoubiquitination of the constitutively active F29/30A mutant. If the C2 and HECT domains interacted in cis, the C2 domain of the Smurf2 CA mutant should be engaged with the ligase-dead CA HECT domain and therefore be unable to inhibit autoubiquitination of the F29/30A mutant. Indeed, we observed that the presence of increasing amounts of the CA mutant had no effect on the activity of F29/30A Smurf2 ( Figure S8B ), whereas the isolated C2 domain efficiently inhibited the F29/30A mutant ( Figure S8C ). In addition, examinations by size-exclusion chromatography revealed that the elution volumes of wild-type and DC2 Smurf2 are consistent with both Smurf2 variants being monomeric in solution ( Figures  S8D-S8E) . Altogether, these results indicate that the interaction between the C2 and HECT domains serves an autoinhibitory function.
The Inhibitory C2 and HECT Domain Interaction Protects Smurf2 from Degradation in Cells
To test whether the in vitro analysis of Smurf2 activity has relevance for Smurf2 function in vivo, we examined steady-state levels of various Smurf2 variants by immunoblotting HEK293T cell lysates ( Figure 4C ). We transiently transfected HEK293T cells with Flag-tagged wild-type Smurf2, the DC2 mutant, and four C2 domain mutants in the context of both a wild-type HECT domain and the respective inactive CA mutant. The transfected cells were grown overnight in the presence and absence of the proteasome inhibitor LLnL. In the case of wild-type Smurf2, the presence of proteasome inhibitor had no effect on Smurf2 steady-state levels. Similarly, the R31A and K83/ 84E mutants, which failed to enhance Smurf2 autoubiquitination in vitro, were unaffected by proteasome inhibition. In contrast, each of the DC2, the F29/30A, and the T56/ L57A mutants displayed low steady-state levels that were substantially enhanced by blocking proteasome function. This effect was confirmed to be dependent on autocatalytic activity since the steady-state levels of the respective CA mutants were unaffected by the presence of proteasome inhibitor ( Figure 4C ). Therefore, interfering with the interaction between the C2 and HECT domains destabilizes Smurf2 proteins in cells in a manner that is dependent on the catalytic cysteine.
Interfering with the C2 and HECT Domain Interface Enhances Smurf2 Activity toward the Small GTPase RhoA To investigate whether the interaction between the C2 and HECT domains regulates substrate ubiquitination in trans, we examined the ubiquitination activity of wild-type, F29/ 30A, or catalytically inactive (CA) Smurf2 toward the small GTPase RhoA, which is a known substrate of the closely related Smurf1 enzyme (Wang et al., 2003) . Levels of mutants in the context of full-length Smurf2 and their respective catalytically inactive (CA) mutants. The cells were grown overnight in the presence or absence of proteasome inhibitor (LLnL). Smurf2 steady-state levels in total cell lysates were determined by immunoblotting with a-Flag antibody. (D) Impaired interactions between the C2 and HECT domains enhance RhoA ubiquitination in trans. Bacterially expressed and purified Flag-tagged RhoA and wild-type, F29/30A, or catalytically inactive (CA) Smurf2 were subjected to in vitro ubiquitination as described . Levels of Ub adducts and unmodified RhoA were detected with a-Ub and a-Flag antibody, respectively. (E) Expression of constitutively active F29/30A, but not wild-type or catalytically inactive (CA) F29/30A Smurf2, decreases RhoA steady-state levels in vivo. HEK293T cells were transiently transfected with empty vector, Flag-tagged RhoA alone, or in combination with wild-type, F29/30A, or F29/30A CA Flag-tagged Smurf2. RhoA and Smurf2 steady-state levels in total cell lysates were determined by immunoblotting with a-Flag antibody. (F) The N-terminal domain of Smad7 inhibits C2 domain binding to the HECT domain. Purified His 6 -HECT domain and increasing amounts of Smad7 NTD were incubated with purified, glutathione Sepharose-immobilized GST, or GST-C2 domain fusion protein. HECT domain binding to the C2 domain was detected by immunoblotting with a-His 5 antibody (''In vitro GST pull-down'' panel). Equivalent His 6 -HECT, GST, and GST-C2 domain levels in the starting material were confirmed by immunoblotting with a-His 5 antibody and Ponceau S staining, respectively, while increasing concentrations of Smad7 NTD were confirmed by immunoblotting with a-Smad7 antibody (''Totals'' panels).
unmodified and ubiquitinated Flag-tagged RhoA were analyzed after immunoprecipitation using a-RhoA and a-Ub antibodies ( Figure 4D ). While the level of unmodified RhoA did not change upon addition of wild-type or CA Smurf2 ( Figure 4D, bottom panel) , RhoA was efficiently ubiquitinated by the F29/30A Smurf2 mutant as revealed by the significant decrease of unmodified RhoA levels ( Figure 4D, bottom panel) and the appearance of ubiquitinated species in the presence of the Smurf2 F29/30A mutant ( Figure 4D, top panel) .
To examine Smurf2-dependent RhoA degradation in vivo, HEK293T cells were transiently transfected with Flag-tagged RhoA together with either Flag-tagged wildtype, F29/30A, or F29/30A CA Smurf2. Consistent with the in vitro RhoA ubiquitination assays ( Figure 4D ) and previous observations (Wang et al., 2003) , RhoA steady-state levels were unaffected by the presence of wild-type Smurf2 ( Figure 4E ). In contrast, RhoA was significantly destabilized in the presence of the gain-of-function F29/30A mutant in a manner that was dependent on the catalytic cysteine. Although initial studies with Smurf1 and Smurf2 suggested that RhoA is a Smurf1-specific target (Schwamborn et al., 2007; Wang et al., 2003) , our in vitro and in vivo studies establish that Smurf2 can target RhoA for ubiquitination. However, in contrast to Smurf1, Smurf2 activity toward RhoA is restricted by the intramolecular interaction between the Smurf2 C2 and HECT domains. While the sequences of the C2 and HECT domains are highly conserved between Smurf1 and Smurf2, they are not identical (92% identity for the C2 domain and 85% identity for the HECT domain). Thus, the differential regulation of Smurf1 and Smurf2 toward RhoA may be due to the distinct residues in these domains. In addition, there is considerable divergence in the region between the C2 and HECT domains of Smurf1 and Smurf2. In particular the longer intervening sequence in Smurf2, which contains a third WW domain not found in Smurf1, may allow the C2 domain to achieve the correct orientation to confer intramolecular inhibition on the HECT domain. Thus, interfering with the interface between the C2 and HECT domains stimulates Smurf2 autoubiquitination and substrate ubiquitination in vitro and promotes Smurf2 and RhoA degradation in cells.
The N-Terminal Domain of Smad7 Antagonizes the Interaction between the Smurf2 C2 and HECT Domains The adaptor protein Smad7 plays a critical role in the regulation of Smurf-dependent ubiquitination by coupling HECT domain activity to substrate recruitment Ogunjimi et al., 2005) . Accordingly, coexpression of Smad7 with Smurf2 destabilizes Smurf2 protein via autoubiquitination , suggesting that in addition to facilitating E2 recruitment, Smad7 might relieve C2 domain-dependent autoinhibition. Therefore, we tested whether the Smad7 N-terminal domain (NTD) could compete with the C2 domain for HECT domain binding. To separate Smurf2 activation due to NTD-mediated enhancement of E2 binding from that due to competition between the C2 domain and the NTD for HECT domain binding, we performed GST pulldown experiments rather than in vitro autoubiquitination assays. We incubated immobilized GST-tagged C2 domain with His 6 -tagged HECT domain and increasing amounts of Smad7 NTD and detected HECT domain binding to the C2 domain using a-His 5 antibody ( Figure 4F ). As expected from our NMR and biochemical studies ( Figures  1, 3C-3E , and 4A-4E), the Smurf2 C2 domain interacted with the HECT domain in the absence of Smad7 NTD. However, increasing concentrations of Smad7 NTD interfered with HECT domain binding to the C2 domain.
Unfortunately, low expression levels and solubility of the Smad7 NTD precluded NMR analysis of the binding interface between the Smad7 NTD and the Smurf2 HECT domain. However, coupled with the interaction between the Smurf2 WW2-3 domains and a proline-rich motif directly C-terminal to the Smad7 NTD (Chong et al., 2006; Kavsak et al., 2000) that facilitates NTD binding to the Smurf2 HECT domain, the observed competition demonstrates that Smad7 can relieve Smurf2 autoinhibition by displacing the C2 domain from the HECT domain.
A Subset of C2-WW-HECT-Domain E3s Is Regulated by Their C2 Domains
The common domain architecture suggests that the autoinhibition mechanism found for Smurf2 may be conserved in other C2-WW-HECT-domain E3s. To test whether autoinhibition by their C2 domains regulates Nedd4/Rsp5p-family members other than Smurf2, we performed autoubiquitination assays with Rsp5p, Nedd4-1, AIP4, and WWP2 enzymes and their respective DC2 mutants (Figure 5) . Levels of unmodified and ubiquitinated protein were detected by SDS-PAGE, immunoblotted with a-Ub antibody, and quantified by chemiluminescence imaging. As for Smurf2, wild-type Nedd4-1 and WWP2 enzymes showed low ubiquitination levels that were significantly enhanced upon deletion of their C2 domains ( Figure 5 ). In contrast, we detected almost no difference in the autoubiquitination efficiency for Rsp5p and AIP4 in the absence or presence of their C2 domains ( Figure 5 ). Ub thioester assays performed with the truncated wild-type and DC2 Nedd4/Rsp5p-family proteins (À4aa or -5aa in the case of Nedd4-1) confirmed that the Ub thioester formation in Rsp5p is not regulated by its C2 domain (data not shown). Unfortunately, Ub thioester assays for the other C2-WW-HECT E3s were inconclusive because the full-length proteins were ill behaved during SDS-PAGE under nonreducing conditions (data not shown).
Consistent with these results, deletion of the C2 domain in AIP4/Itch and Rsp5p has no significant effect on AIP4 autocatalytic activity or Rsp5p activity toward Fur4p and Gap1p (Gallagher et al., 2006; Springael et al., 1999; Wang et al., 2001) . Furthermore, wild-type Rsp5p is known to efficiently form Ub thioester adducts and to ubiquitinate itself (Salvat et al., 2004) . These results support the notion that Rsp5p and AIP4 are not regulated by their C2 domains. In contrast, human Nedd4-1 lacking the C2 domain downregulates the epithelial sodium channel ENaC more potently in vivo than the wild-type enzyme (Kamynina et al., 2001; Snyder et al., 2001) . This suggests that the C2 domain of Nedd4-1 has an inhibitory function. Altogether, these studies define two subclasses of C2-WW-HECT-domain E3s that are distinguished based on differential autoregulation by their C2 domains.
DISCUSSION
Ub protein ligases are a large family of modular proteins that are essential for regulating the trafficking and degradation of components of various signaling pathways. Given their importance, it is not surprising that E3 enzymes are subject to multiple layers of regulation. However, since most studies have focused on E3 regulation at the level of substrate recognition, much remains to be learned about the regulation of E3 activity itself. Here, we addressed the role of intra-and intermolecular interactions in the regulation of the C2-WW-HECT-domain Ub ligase Smurf2. We demonstrate that the N-terminal C2 domain interacts with the C-terminal HECT domain in direct proximity to the catalytic cysteine and inhibits Ub thioester formation ( Figures 3D-3E) . Furthermore, we show that the N-terminal domain (NTD) of Smad7, which is an adaptor protein that recruits Smurf2 to a number of its targets, disrupts the interaction between the Smurf2 C2 and HECT domains ( Figure 4F ). We propose a model in which autoinhibition of the Smurf2 HECT domain by the C2 domain protects the steady-state level of the Ub ligase in cells and is relieved by adaptor-mediated substrate targeting (Figure 6 ).
Preventing Futile Cycles of Autocatalytic Ubiquitination and Degradation
Ub protein ligases can catalyze the ubiquitination of both their substrates and themselves (Fang and Weissman, 2004; Huibregtse et al., 1995) . In many cases, E3 autoubiquitination mediates their proteasome-dependent degradation, suggesting that autoubiquitination represents a regulatory mechanism to control the abundance of Ub protein ligases in cells (Fang and Weissman, 2004; Gallagher et al., 2006; Ogunjimi et al., 2005) . In addition, nonproteolytic functions have recently been described for E3 autoubiquitination. While the generation of mixed polyUb chains by autoubiquitination protects the RING fingertype E3 Ring1B from proteasome-dependent degradation and activates it for substrate ubiquitination (Ben-Saadon et al., 2006) , autoubiquitination of Nedd4/Rsp5p-family members has been identified as a critical determinant for their ability to ubiquitinate Ub receptor proteins (Woelk et al., 2006) . Interestingly, in both cases E3 autoubiquitination is essential for substrate monoubiquitination. (A) Bacterially expressed and purified wildtype and DC2 C2-WW-HECT-domain E3s (Rsp5p, Nedd4-1, AIP4, and WWP2) were used for in vitro autoubiquitination assays in the absence or presence of E1 enzyme. Formation of E3-Ub adducts was detected after a reaction time of 1 hr by immunoblotting with a-Ub antibody (top panel), while E3 levels were detected by Ponceau S staining (bottom panel). (B) E3-Ub adduct formation in wild-type and DC2 C2-WW-HECT-domain E3s (Smurf2, Rsp5p, Nedd4-1, AIP4, and WWP2) was quantified by chemiluminescence imaging using a-Ub immunoblots. Ubiquitination levels of wild-type and DC2 Smurf2 were quantified after a reaction time of 1 hr using experiments shown in Figure 4A (bottom panel). Autoubiquitination efficiencies were normalized to those of the wild-type enzymes and are plotted as the mean ± SE of triplicates from representative experiments.
However, the presence of active catalytic HECT domains in Ub protein ligases raises an important question as to how the premature autoubiquitination and degradation of E3s are controlled. This can be critical to prevent futile cycles of production and degradation of Ub protein ligases and to ensure that the short-lived E3s are sufficiently stable to gain access to their bona fide substrates. This issue becomes particularly problematic for Ub protein ligases such as Smurf enzymes that employ a range of adaptor proteins to target their substrates (Bonni et al., 2001; Kavsak et al., 2000) . Smurf2 targets itself for Ub-dependent degradation ( Figure 4C ; Ogunjimi et al., 2005) . Our studies suggest that in the absence of adaptor proteins and bona fide substrates, Smurf2 autoubiquitination and degradation is prevented by intramolecular association of the C2 domain with the catalytic HECT domain (Figures 3, 4 , and S8). This interaction is antagonized by binding of the NTD of the adaptor protein Smad7 to the Smurf2 HECT domain ( Figure 4F ). In addition, the Smad7 NTD further enhances the catalytic activity of the Smurf2 ligase by recruiting the E2, UbcH7, to the HECT domain . By releasing C2-mediated autoinhibition, stimulating E2 binding, and recruiting Smurf targets, Smad7 functions at multiple levels to control Smurf activity and ensure specificity in Smurfcatalyzed ubiquitination.
C2 Domains Serve Autoinhibitory Functions in a Subset of C2-WW-HECT Domain E3s
Using structural and biochemical studies, we have defined an autoinhibitory mechanism for the HECT-type Ub ligase Smurf2 that extends to other Nedd4/Rsp5p-family E3s. We showed that interfering with the interface between the Smurf2 C2 and HECT domains enables Ub thioester formation and enhances Smurf2 autoubiquitination and Smurf2 activity toward the small GTPase RhoA ( Figures  3E and 4A-4E) . Similarly, deletion of the C2 domain in Nedd4-1 and WWP2 promotes their autoubiquitination in vitro ( Figure 5 ) and enhances downregulation of the epithelial sodium channel ENaC by Nedd4-1 in vivo (Kamynina et al., 2001; Snyder et al., 2001) . In contrast, deletion of the C2 domain in AIP4/Itch and Rsp5p has no significant effect on their autocatalytic activities or Rsp5p activity toward Fur4p and Gap1p ( Figure 5 ; Gallagher et al., 2006; Springael et al., 1999; Wang et al., 2001) . Thus, while the mechanism of regulating E3 activity by interactions between the C2 and HECT domains is relevant to some Nedd4/Rsp5p-family members, it is not inclusive of all C2-WW-HECT-domain E3s.
Finally, dysregulation of Ub-dependent degradation of signaling proteins is associated with the development and progression of cancer and other human diseases. This has spurred considerable interest in modulating E3 activities as a specific means for developing anticancer drugs (Hoeller et al., 2006) . Our results show that the Smurf2 HECT domain functions as a platform that organizes multiple protein-protein interactions to regulate its catalytic activity. The structural information described in this study therefore not only provides new insight into the regulation of a subset of HECT-type E3s but also offers various starting points for manipulating the activities of these enzymes by small molecule inhibitors to target them for cancer therapy. In the nucleus, Smurf2 (blue) activity is inhibited due to the intramolecular interaction between the N-terminal C2 and the C-terminal catalytic HECT domain. This interaction serves to preserve the steady-state level of Smurf2 by preventing futile cycles of autoubiquitination and degradation. TGF-b-induced expression of the adaptor protein Smad7 (orange) results in complex formation between Smurf2 and Smad7 . The interaction with Smad7 activates the Smurf2 ligase as the Smad7 NTD displaces the C2 domain from the HECT domain. The activated Smurf2-Smad7 complex can then target nuclear substrates for Ub-dependent degradation or is exported to the cytoplasm. In the cytoplasm, the Smurf2-Smad7 complex associates with activated TGF-b receptor complexes (TbR; shown in green) at the membrane (depicted as a black line) via the displaced C2 domain and the Smad7 MH2 domain (Hayashi et al., 1997) to target TGF-b receptor complexes, Smad7 and Smurf2 for Ub-dependent degradation and ultimately terminate TGF-b signaling.
